Table 1 Baseline characteristics of the study population
N | Mean ± SD or n of patients | Range | |
|---|---|---|---|
Sex, male/female | 90 | 51/39 | |
Age (years) | 90 | 73.3 ± 11.3 | 46.0–93.8 |
Height (cm) | 84 | 170.2 ± 10.5 | 142–188 |
Weight (kg) | 84 | 80.9 ± 16.2 | 38–118 |
BMI (kg/m2) | 84 | 27.8 ± 4.4 | 18.9–37.7 |
Heart rate (bpm) | 59 | 67 ± 13 | 45–120 |
eGFR | 89 | 75 ± 18 | 21–107 |
Hypertension | 90 | 66 (73.3%) | |
Dyslipidemia | 90 | 73 (81.1%) | |
Diabetes | 90 | 20 (22.2%) | |
Smoker | 89 | 31 (34.8%) | |
Morbus cordis coronaries | 87 | 36 (41.4%) | |
NYHA class | 74 | ||
I | 3 (4.1%) | ||
II | 47 (63.5%) | ||
III | 22 (29.7%) | ||
IV | 2 (2.7%) | ||
Valve morphology | 90 | ||
Bicuspid | 36 (40.0%) | ||
Tricuspid | 54 (60.0%) | ||
TTE values | |||
LVEF (%) | 90 | 60.0 ± 9.2 | 35.0–78.0 |
LVEDD (mm) | 90 | 49.1 ± 6.8 | 31.0–73.0 |
LVESD (mm) | 70 | 32.8 ± 7.5 | 20.0–60.0 |
AVA (cm2) | 89 | 0.7 ± 0.1 | 0.4–1.0 |
Mean gradient (mmHg) | 89 | 46 ± 14 | 15.0–90.0 |
Vmax (m/s) | 90 | 4.3 ± 0.6 | 2.7–6.1 |
LFLG-AS | 90 | 4 (4%) | |